SCHEMBL9999113

SCHEMBL9999113

O=C(OCc1ccccc1)c1cccc(CN2CN(c3ccccc3)C3(CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCNCC3)C2=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
MAPT P10636 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPC1L1 Q9UHC9 3/20 0.40
CYP2C9 P11712 1/20 0.40
FOLH1 Q04609 4/20 0.39
BDKRB2 P30411 1/20 0.38
KLK3 P07288 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL318706 0.95 KMT2A (0.47) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2
SCHEMBL9999132 0.91 MEN1 (0.46) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2
SCHEMBL319313 0.85 MEN1 (0.46) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2
SCHEMBL18601789 0.85 MEN1 (0.45) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2
SCHEMBL318441 0.85 RAB9A (0.46) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2
SCHEMBL320054 0.85 MEN1 (0.49) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2
SCHEMBL318592 0.84 KMT2A (0.51) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2
SCHEMBL318802 0.83 MEN1 (0.44) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2
SCHEMBL318817 0.83 MEN1 (0.44) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2
SCHEMBL319002 0.82 MEN1 (0.46) KMT2AMEN1CYP3A4CYP2D6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582701-A1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE Altos Therapeutics, LLC (US) 2013-04-24 EP disclosed
WO-2011160084-A1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE Altos Therapeutics, LLC (US) 2011-12-22 WO disclosed